Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients
Background: Soluble FAS (sFAS) is an apoptosis "programmed cell death" marker and results from shedding of FAS molecules during activation of FAS mediated apoptosis. There are several important reasons that Apoptosis is deregulated in active systemic lupus erythematosus and FAS is over exp...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Isfahan University of Medical Sciences
2010-01-01
|
| Series: | مجله دانشکده پزشکی اصفهان |
| Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/339 |
| _version_ | 1797716608275185664 |
|---|---|
| author | Maryam Sahebari Mohammad Reza Hatef-fard Zahra Rezaie Yazdi Mahmoud Mahmoudi Masoud Saghafi Mahnaz Abbasi |
| author_facet | Maryam Sahebari Mohammad Reza Hatef-fard Zahra Rezaie Yazdi Mahmoud Mahmoudi Masoud Saghafi Mahnaz Abbasi |
| author_sort | Maryam Sahebari |
| collection | DOAJ |
| description | Background: Soluble FAS (sFAS) is an apoptosis "programmed cell death" marker and results from shedding of FAS molecules during activation of FAS mediated apoptosis. There are several important reasons that Apoptosis is deregulated in active systemic lupus erythematosus and FAS is over expressed by T-cells; although the role of its soluble form (sFas) is unclear. Methods: We have investigated the correlation between serum levels of sFAS and active organ damages in lupus patients. Our study was performed on 114 systemic lupus erythematosus patients, compared with 50 randomly selected sex-, age- and race-matched healthy controls. The patients were randomly selected in different phases of disease activity. All the physical examinations and laboratory parameters were collected for determination of the SLEDAI index. sFAS, Anti-dsDNA, C3, and C4 levels were determined using a commercially available ELISA kit. Findings: There was a significant difference between serum levels of sFAS in the case and control groups (P = 0.001). We found a significant correlation coefficient between the sFAS and SLEDAI2K variables (P = 0.001, r= 0.494). It was a significant statistical difference between serum levels of sFAS in patients with rising in amount of proteinuria more than 0.5 g/l in 24h urine sample collection and without it (P = 0.04), and central nervous system (CNS) damage versus normal CNS patients (P = 0.006). It was not difference between sFAS and cardiac damage (P = 0.05) but it was near significant difference. Conclusion: We found a correlation between sFAS serum levels and central nervous system involvement and rising in amounts of proteinuria in systemic lupus erythematosus patients. Key words: Systemic lupus erythematosus, Central nervous system, Proteinuria, sFAS (Apo-1) CD95, Carditis. |
| first_indexed | 2024-03-12T08:24:58Z |
| format | Article |
| id | doaj.art-b1b37d86386a4ce9bd310fbd455dcffd |
| institution | Directory Open Access Journal |
| issn | 1027-7595 1735-854X |
| language | fas |
| last_indexed | 2024-03-12T08:24:58Z |
| publishDate | 2010-01-01 |
| publisher | Isfahan University of Medical Sciences |
| record_format | Article |
| series | مجله دانشکده پزشکی اصفهان |
| spelling | doaj.art-b1b37d86386a4ce9bd310fbd455dcffd2023-09-02T18:12:47ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2010-01-0127101698709331Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus PatientsMaryam Sahebari0Mohammad Reza Hatef-fard1Zahra Rezaie Yazdi2Mahmoud Mahmoudi3Masoud Saghafi4Mahnaz Abbasi5Assistant Professor of Rheumatology, Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, MashhadAssociate Professor of Rheumatology. Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, MashhadAssociate Professor of Rheumatology. Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, MashhadProfessor of Immunology, Immunology Research Center, Mashhad University of Medical Sciences, MashhadAssociate Professor of Rheumatology. Rheumatic Diseases Research Center, Mashhad University of Medical SciencesAssistant Professor of Rheumatology, Metabolic Research Center, Qazvin University of Medical Sciences, QazvinBackground: Soluble FAS (sFAS) is an apoptosis "programmed cell death" marker and results from shedding of FAS molecules during activation of FAS mediated apoptosis. There are several important reasons that Apoptosis is deregulated in active systemic lupus erythematosus and FAS is over expressed by T-cells; although the role of its soluble form (sFas) is unclear. Methods: We have investigated the correlation between serum levels of sFAS and active organ damages in lupus patients. Our study was performed on 114 systemic lupus erythematosus patients, compared with 50 randomly selected sex-, age- and race-matched healthy controls. The patients were randomly selected in different phases of disease activity. All the physical examinations and laboratory parameters were collected for determination of the SLEDAI index. sFAS, Anti-dsDNA, C3, and C4 levels were determined using a commercially available ELISA kit. Findings: There was a significant difference between serum levels of sFAS in the case and control groups (P = 0.001). We found a significant correlation coefficient between the sFAS and SLEDAI2K variables (P = 0.001, r= 0.494). It was a significant statistical difference between serum levels of sFAS in patients with rising in amount of proteinuria more than 0.5 g/l in 24h urine sample collection and without it (P = 0.04), and central nervous system (CNS) damage versus normal CNS patients (P = 0.006). It was not difference between sFAS and cardiac damage (P = 0.05) but it was near significant difference. Conclusion: We found a correlation between sFAS serum levels and central nervous system involvement and rising in amounts of proteinuria in systemic lupus erythematosus patients. Key words: Systemic lupus erythematosus, Central nervous system, Proteinuria, sFAS (Apo-1) CD95, Carditis.http://jims.mui.ac.ir/index.php/jims/article/view/339 |
| spellingShingle | Maryam Sahebari Mohammad Reza Hatef-fard Zahra Rezaie Yazdi Mahmoud Mahmoudi Masoud Saghafi Mahnaz Abbasi Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients مجله دانشکده پزشکی اصفهان |
| title | Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients |
| title_full | Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients |
| title_fullStr | Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients |
| title_full_unstemmed | Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients |
| title_short | Correlation between Serum Levels of Soluble Fas (CD95/Apo-1) and Active Major Organ Damages in Systemic Lupus Erythematosus Patients |
| title_sort | correlation between serum levels of soluble fas cd95 apo 1 and active major organ damages in systemic lupus erythematosus patients |
| url | http://jims.mui.ac.ir/index.php/jims/article/view/339 |
| work_keys_str_mv | AT maryamsahebari correlationbetweenserumlevelsofsolublefascd95apo1andactivemajororgandamagesinsystemiclupuserythematosuspatients AT mohammadrezahateffard correlationbetweenserumlevelsofsolublefascd95apo1andactivemajororgandamagesinsystemiclupuserythematosuspatients AT zahrarezaieyazdi correlationbetweenserumlevelsofsolublefascd95apo1andactivemajororgandamagesinsystemiclupuserythematosuspatients AT mahmoudmahmoudi correlationbetweenserumlevelsofsolublefascd95apo1andactivemajororgandamagesinsystemiclupuserythematosuspatients AT masoudsaghafi correlationbetweenserumlevelsofsolublefascd95apo1andactivemajororgandamagesinsystemiclupuserythematosuspatients AT mahnazabbasi correlationbetweenserumlevelsofsolublefascd95apo1andactivemajororgandamagesinsystemiclupuserythematosuspatients |